NPS's Nader on Drug Research, Growth Strategy

Feb. 25 (Bloomberg) -- Francois Nader, chief excutive officer for NPS Pharmaceuticals Inc., talks about cost strategy and product development. Nader speaks with Sara Eisen and Tom Keene on Bloomberg Television's "Surveillance." Stanley Collender, managing director for Qorvis Communications LLC, also speaks. (Source: Bloomberg)

Full Show: Bloomberg Best (09/30)
41:20 - A review of the week's top business stories from the U.S., Europe and Asia. (Source: Bloomberg)
  • Tackling Age Bias in Silicon Valley
  • Is the Tech IPO Drought Over?
  • What to Expect From Alphabet's Oct. 4 Product Event